Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.


OTCPK:MEDVF - Post by User

Post by LongRun78on May 06, 2021 12:51pm
105 Views
Post# 33141505

google "exhaled breath metagenomics"

google "exhaled breath metagenomics"This is what BlowFISH is all about. And also, google "volatile organic compounds (VOCs)" Regarding VOC : "[...] pathway to many diseases, including obesity, inflammatory bowel disease (IBD), type 1 diabetes (T1D) and type 2 diabetes(T2D), inflammatory airway diseases, rheumatoid arthritis (RA), allergy, autism, and cancer [...]" ref : https://www.frontiersin.org/articles/10.3389/fcimb.2020.564194/full This is huge but actually, under the radar, except for scientist like Jeremy Kamil : https://twitter.com/macroliter/status/1389981530068500480?s=20 Name whatever disease you want... if this (inexpensive btw) device is FDA approuved, it will be a game changer. Think about it... countries all around the world could afford it... Africa, East-Asia, South America... I want more than FDA approuval :)
<< Previous
Bullboard Posts
Next >>